First, Mirza et al., 2002, after investigating an ovarian carcinoma cell line, suggested that instead of directly binding to the BIRC5 promoter, p53 inhibits an acetylase enzyme, thus preventing the acetylation of the BIRC5 promoter [91]. Here, BIRC5 is linked to ovarian carcinoma.